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Potential threats 
Our world is caught in the terrible cycle of poverty, illiteracy, 
violence, and devastating disease. Countries have been subject 
to the weighty challenge inherent in addressing the recklessly 
growing population, pervasive unemployment, rising longevity, 
the burden of diseases, insurgencies, and political insecurity (1). 
Although healthcare systems have improved dramatically 
during recent years and new modalities of treatments have 
been introduced, still there are many challenges facing 
healthcare systems and in particular in ophthalmology and eye 
care services which require immediate reform. 
 
A dynamic science 
Ophthalmology has been progressing very quickly in recent 
decades, and is currently present in a reasonable number of 
surgery centers around the world. An enormous change has 
taken place in visual sciences, and despite the fact that no 
study has been made on measurement of growth of science in 
different specialty fields; ophthalmology might well be the 
discipline with the highest number of advancements.  
Presently, the new suture-less and noninvasive microsurgical 
techniques have made a revolutionary change, and the 
mortality as well as morbidity of various diseases has been 
reduced significantly as a result. Progress has been made in 
specific areas. For example, surgical techniques have made 
enormous development in both anterior and posterior ocular 
surgeries, and patients are able to resume their ordinary lives 
only few minutes after the surgeries. Post-operation 
complications have significantly decreased and the new 
generation of antibiotics has been introduced. However, there 
is much that still needs to be accomplished. 
 
Major ophthalmic challenges 
On the other hand, blindness and visual impairment act as 
significant and ubiquitous health problems.  Although new 
technologies are rapidly progressing, visual impairment is still a 
noteworthy problem to worldwide healthcare systems. For that 
reason, international organizations have regulated that in the 
various universal projects, ophthalmic services as well as 
teaching facilities in visual sciences have to increase 
significantly.  
Currently, ophthalmology deals with major causes of blindness 
including cataracts, uncorrected refractive errors, glaucoma, 
age-related macular degeneration, corneal opacities, diabetic 
retinopathy, pediatric ocular diseases, trachoma and many 
infectious diseases. Although innovative treatment modalities 
have been presented well, so far no definitive treatment has 
been introduced for most of the chronic diseases.  
According 2012 world health organization fact sheets, 285 
million people around the world are visually impaired. 
Specifically, 39 million are blind and 246 million have low vision. 
Universally, uncorrected refractive errors are one of the major 
reasons for visual impairment and cataracts remain the 
conspicuous reason for blindness in developing countries. The 
reality of it is that 80% of all visual impairment could be 
prevented or cured (2). Unfortunately, around 90 percent of 
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visually impaired individuals live in developing countries. Global 
dissemination of visual impairment reveals a disproportionately 
large prevalence in low income countries. In developing 
countries, trachoma and cataracts are the largest causes of 
avoidable visual impairment and there is both a deficiency and 
inequity in accessibility of eye care. These are the major 
challenges facing today’s ophthalmologists worldwide. 
On the other hand, effectiveness of off-label medications, 
presence of chronic diseases, safety of biological drugs, high 
cost of retinal procedures and intraocular lenses, legal issues in 
corneal donation, and economic instability in developing 
countries has caused a deferral of surgeries  represent major 
problems that have yet to be resolved.  
There are also the numerous challenges that ophthalmic 
education has faced.  Lack of specialized ophthalmic nurses to 
educate patients, lack of universal clinical guidelines to manage 
the cases in the uniform format, inability to teach residents in 
common ocular surgeries are the other problems in most 
developing countries.  
Inequality in distribution of ophthalmologists is one of the 
major problems in most areas. Private ophthalmic hospitals are 
one of the major threats to public health. Many cases have 
been shifted to private hospitals where the level of education 
has been compromised at the same time. In fact, there are 
many other serious problems we plan to discuss in future issues 
of the journal. 
 
Characteristics of this journal 
Medical Hypothesis, Discovery & Innovation (MEHDI) 
Ophthalmology Journal aims to create an environment that will 
cultivate publishing of important innovative ideas in solving the 
aforementioned problems facing to ophthalmology: 
hypotheses, and practice-related material, robust dialogue 
among innovative professionals, faster cycles of innovation, and 
wider distribution of advances in surgical techniques and 
instruments.  
Our goal is speed in publishing information and making it 
readily available in articles in various databases. Usually, in 
most scientific journals, manuscripts from well-known authors 
are routinely published as the author is a known commodity. 
However, we take the view that a fresh-minded, young author 
could have an idea that could conceivably change the direction 
of future researches. 
We believe strongly that any hypothesis or idea might provide 
opportunities to improve life. Similarly, ideas that result in 
better allocation of human resources and/or access of people 
to healthcare and medical services are also anticipated. 
Therefore, we plan to make those ideas highly visible. 
Together with the world health organization, international 
agency for the prevention of blindness, international non-
governmental organizations, and the international ophthalmic 
community, we can all advocate for support to prevent and 
treat visual impairment and bring together novel ideas to solve 
challenges facing today's ophthalmology. Close coordination, as 
well as sublimation of ego and the natural desire to control, 
would be required. Meticulous coordination, regular 
communication, and unwavering commitment will be essential 
for success. Ophthalmologists in developed regions would have 
a precise role and responsibility in the accomplishment of 
Vision for the Future (3). Therefore, we welcome your 
contribution in all future issues.  
And finally, more care, more research and most of all more 
education are required if we are to combat the increasing rates 
of blindness and other visual impairments globally. Success is 
about teamwork and strong partners. Therefore, we ask your 
cooperation for a better future. 
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